Inhibrx Biosciences盘前大涨6.2% 路透报道其实验性抗癌药物引默克及同业竞逐

美股速递
Apr 22

生物科技公司Inhibrx Biosciences股价在盘前交易中强势攀升6.2%,此前路透社报道称,该公司旗下的一款实验性抗癌药物已吸引制药巨头默克及其竞争对手的收购兴趣。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10